Ireland
--:--IST
Priya Life Science Sponsor trial record
Sponsor · clinical trials

Société Française d'Anesthésie et de Réanimation clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our France register with Société Française d'Anesthésie et de Réanimation as lead sponsor. Synced 15 Nov 2026
7Current trials
3Recruiting now
0Drugs in these trials
1Trial register
At a glance

Société Française d'Anesthésie et de Réanimation is the lead sponsor of 7 current clinical trials in our France register. 3 are recruiting patients now. All registered phases are Observational. The most-studied condition is Poisoning.

ClinicalTrials.gov trials by status

  • Recruiting343%
  • Not yet open457%

Trials by phase

  • Observational7100%
01

Clinical trials sponsored by Société Française d'Anesthésie et de Réanimation

7 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Perioperative Hemostasis Management in Liver Transplantation
NCT06257407 · ClinicalTrials.gov ↗ · Liver Transplant; Complications
Observational Recruiting 2024-10 France
ICU Management of Brain-Dead Donors Before Multi-Organ Procurement and Factors Associated With the Number of Organs Retrieved
NCT06768515 · ClinicalTrials.gov ↗ · Death, Brain
Observational Recruiting 2025-04 France
Factors Associated With Early Readmission in Critical Care
NCT07182916 · ClinicalTrials.gov ↗ · Early Readmission to the ICU
Observational Recruiting 2026-01 France
Prognostic Factors in Critically Ill Patients Admitted After Caustic Ingestion in France
NCT07526220 · ClinicalTrials.gov ↗ · Poisoning
Observational Not yet open 2026-04 France
Impact of Implementing a National Classification of Surgical Emergencies on Postoperative Morbidity and Mortality: a Prospective Multicenter Observational Study After Implementation.
NCT07317635 · ClinicalTrials.gov ↗ · Surgical Emergencies
Observational Not yet open 2026-02 France
Cangrelor As Treatment for Cardiac Surgery Associated With Heparin Induced Thrombocytopenia
NCT07817680 · ClinicalTrials.gov ↗ · Heparin-induced Thrombocytopenia
Observational Not yet open 2026-11 France
Diagnosis and Treatment of Late Neurological Ischemic Deficit in Patients Suffering From Subarachnoid Hemorrhage.
NCT07634172 · ClinicalTrials.gov ↗ · Aneurysmal Subarachnoid Haemorrhage, Delayed Ischemic Neurological Deficit
Observational Not yet open 2026-06 France

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in Société Française d'Anesthésie et de Réanimation trials

8 conditions
Poisoning1Liver Transplant; Complications1Death, Brain1Surgical Emergencies1Heparin-induced Thrombocytopenia1Aneurysmal Subarachnoid Haemorrhage1Delayed Ischemic Neurological Deficit1Early Readmission to the ICU1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in France73

A trial with sites in more than one country appears in each of those registers.

04

Questions about Société Française d'Anesthésie et de Réanimation trials

How many clinical trials does Société Française d'Anesthésie et de Réanimation sponsor?

Société Française d'Anesthésie et de Réanimation is the lead sponsor of 7 current trials on ClinicalTrials.gov in our France register, as of the registry sync on 15 November 2026. Completed and withdrawn studies are not counted.

Are Société Française d'Anesthésie et de Réanimation trials recruiting?

Yes. 3 of its 7 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 15 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.